GlassScriptPhysician profile
Steven P Manuli
NPI 1245236959
$274,008.99
in general payments reported to CMS, 2019-2025
55 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $16K · 2021: $5,139 · 2022: $63K · 2023: $83K · 2024: $41K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $107K · Travel and Lodging: $31K · Food and Beverage: $12K · Consulting Fee: $9,576 · Honoraria: $9,493 · Education: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $106,507.81 |
| Travel and Lodging | $31,468.68 |
| Food and Beverage | $11,551.06 |
| Consulting Fee | $9,576.00 |
| Honoraria | $9,493.00 |
| Education | $201.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $177,920.59 | 2019-2025 | Korlym |
| Idorsia Pharmaceuticals US INC | $33,894.70 | 2022-2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $22,105.01 | 2019-2025 | |
| Axsome Therapeutics, INC. | $10,713.93 | 2023-2025 | Sunosi, Auvelity |
| Pfizer INC. | $9,689.69 | 2019-2025 | |
| Harmony Biosciences LLC | $4,130.84 | 2020-2025 | Wakix |
| Novo Nordisk INC | $2,445.81 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $1,706.86 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,685.36 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $1,548.81 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $975.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $619.16 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $609.68 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $580.45 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $571.57 | 2019-2022 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $511.79 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $482.42 | 2019-2025 | Capvaxive, Gardasil 9, Verquvo |
| Janssen Pharmaceuticals, INC | $428.33 | 2019-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $419.66 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $307.69 | 2019-2023 | Veozah |
| Teva Pharmaceuticals USA, INC. | $255.80 | 2019-2022 | |
| Allergan, INC. | $224.34 | 2019-2021 | |
| Mylan Specialty L.P. | $187.95 | 2019-2024 | Yupelri, Yupelri |
| Biohaven Pharmaceuticals, INC. | $180.33 | 2021 | |
| Amarin Pharma, INC. | $165.34 | 2019-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $163.40 | 2023-2025 | Lumryz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.60 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $136.19 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $121.34 | 2019-2023 | Seglentis, Livalo |
| Exact Sciences Corporation | $92.75 | 2023-2025 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $87.36 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $84.34 | 2024 | Recorlev |
| Upsher-Smith Laboratories LLC | $72.80 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $67.81 | 2023-2025 | Gemtesa |
| Eisai INC. | $64.20 | 2019-2022 | |
| Dexcom, INC. | $62.00 | 2022-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $61.12 | 2019-2021 | |
| Viatris Specialty LLC | $60.22 | 2025 | Yupelri |
| Kyowa Kirin, INC. | $40.63 | 2024 | Crysvita |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.35 | 2023-2024 | Caplyta |
| Cashflow Solutions, LLC | $33.67 | 2024-2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| E.R. Squibb & Sons, L.L.C. | $31.59 | 2022 | |
| Phathom Pharmaceuticals, INC. | $31.55 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $30.79 | 2022 | |
| Inspire Medical Systems, INC. | $30.55 | 2024 | Inspire |
| Radius Health, INC. | $26.60 | 2024 | Tymlos |
| Arbor Pharmaceuticals, INC. | $25.78 | 2019-2020 | |
| Tris Pharma INC | $21.22 | 2025 | Dyanavel Xr |
| Endo USA, INC. | $19.46 | 2025 | Xiaflex, Aveed |
| Smith+Nephew, INC. | $19.21 | 2019 | |
| Horizon Therapeutics Plc | $18.30 | 2020 | |
| Esperion Therapeutics, INC. | $15.25 | 2025 | Nexletol |
| Medtronic Minimed, INC. | $15.20 | 2020 | |
| Azurity Pharmaceuticals, INC. | $13.55 | 2024 | Horizant |
| Aytu Biopharma, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Manuli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.